Novartis to lay off 275 workers in Libertyville with closure of plant – Chicago Tribune*

The Bannockburn-headquartered company plans to consolidate manufacturing of gene therapy medication Zolgensma at its North Carolina manufacturing facility. It plans to fully wind down operations at the Libertyville plant by the end of 2023.
2 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
marko
3 years ago

This is getting beyond concerning and more than just serious, there is a fundamental flaw with Illinois that is causing it to implode. We all know the weather is not the greatest, strike one. The terrain leaves something to be desired especially among the younger generations who simply dont want to live in boring places, strike 2. None of this is really new but in the past IL was a place to get a good paying job, good communities, access to top schools and talent, average taxes and cheap energy – all that is gone, strike three. We can’t do… Read more »

Giddyap
3 years ago

The Latest Fortune 500 Company — Pharmaceutical Giant Novartis — To Dump Illinois — ROLL CALL OF FORTUNE 500 EXITS THIS YEAR INCLUDES BOEING, CATERPILLAR, TYSON, AND TENNECO 

SIGN UP HERE FOR FREE WIREPOINTS DAILY NEWSLETTER

Home Page Signup
First
Last
Check what you would like to receive:

FOLLOW US

 

WIREPOINTS ORIGINAL STORIES

Mark Glennon on AM560’s Morning Answer: Chicago pension buyout plan mostly shifts debt rather than eliminating it, property tax surge doubles inflation over three decades

Chicago’s political leadership is floating a pension buyout program as evidence it is seriously addressing the city’s thirty-six-billion-dollar unfunded pension liability, but Mark Glennon, founder of the Illinois policy research organization Wirepoints, said that the proposal moves debt from one column to another rather than reducing it, and that the broader fiscal picture facing the city continues to deteriorate across every measurable dimension. Audio here.

Read More »

WE’RE A NONPROFIT AND YOUR CONTRIBUTIONS ARE DEDUCTIBLE.

SEARCH ALL HISTORY

CONTACT / TERMS OF USE